Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
about
Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretionPolyamines and cancer: implications for chemotherapy and chemopreventionMetabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate CancerThe polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDiscovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylaseThe genome of Yoka poxvirus.Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.Keratin-6 driven ODC expression to hair follicle keratinocytes enhances stemness and tumorigenesis by negatively regulating Notch.Apigenin and its impact on gastrointestinal cancers.Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm-associated JAK2 V617F mutantModulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.Arginase in retinopathy.Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy.Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.Characterization of transgenic mice with overexpression of spermidine synthase.Vitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines.Non-canonical Hedgehog/AMPK-Mediated Control of Polyamine Metabolism Supports Neuronal and Medulloblastoma Cell Growth.S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.Knockdown of antizyme inhibitor decreases prostate tumor growth in vivoCurrent status of the polyamine research fieldArginine metabolism and nutrition in growth, health and diseaseMammalian polyamine metabolism and functionPolyamine catabolism and disease.Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients.Difluoromethylornithine in cancer: new advances.Differential expression of ornithine decarboxylase antizyme inhibitors and antizymes in rodent tissues and human cell lines.Inducible expression of antizyme 1 in prostate cancer cell lines after lentivirus mediated gene transfer.Different changes in protein and phosphoprotein levels result from serum starvation of high-grade glioma and adenocarcinoma cell lines.Effects of exposure to DAMPS and GSM signals on ornithine decarboxylase (ODC) activity: II. SH-SY5Y human neuroblastoma cells.A role for antizyme inhibitor in cell proliferationRegulation of Polyamine Metabolism by Curcumin for Cancer Prevention and Therapy.Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.Polyamines and Cancer.Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases.Systemic overexpression of antizyme 1 in mouse reduces ornithine decarboxylase activity without major changes in tissue polyamine homeostasis.Engineering allosteric regulation into the hinge region of a circularly permuted TEM-1 beta-lactamaseCurcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies
P2860
Q24311326-9AE14071-3CA5-47F5-AA11-586B1D13CAB3Q26864516-6FB2A27F-563D-4141-91C0-865AFDB1EDCDQ28828395-AA5EBEC0-47C1-4D28-A16E-60AAE9F1BC15Q33761692-050C9FC4-55D1-40CB-9A7A-B1419B166AF7Q33883491-573F360B-7F17-4883-B334-3EDE8A7BA764Q33981035-7A335BA1-1835-4EE8-86DF-AE24ED4D6D3EQ34107313-462EB684-0614-40CF-A9E4-A6FDBD688E8DQ34194412-635B191E-BE1D-49B3-8299-7A4E2042D10BQ34314564-1A12163F-5114-41E4-82AE-E3601F220CDFQ34542215-7018C2FF-3286-45F2-AE4E-57AFA5342D1DQ34618239-029D4C8C-A9FE-45AE-9D75-B3C29074100FQ34800913-8C8FF8EC-49ED-4879-904E-C62C31F3FFD5Q35386279-F935691A-0A9E-4CC0-A030-DFCE9808B3D9Q35559033-54CC17F9-1593-4121-AD96-5F727744C8A8Q35580905-1F606B67-F03A-44AE-BD5B-A95FBD494A72Q35632971-DA52219F-1ACA-40BE-B6CD-2EB811A20389Q35667854-BEF0E053-DE34-4816-9EA0-29E531B3B418Q36168155-F236898C-2381-4AD9-B97F-CEF23820462DQ36401976-B71547C6-9458-4994-B898-EE3DB93FB252Q36638469-2858AD9B-C9DA-4B27-A752-AC4D47B15D36Q36838564-AA45BDA5-A16F-41AE-8B52-B2814710BEC9Q37179500-5E4D8AEB-E521-468E-8A5D-BD44261AFD03Q37365983-033028E4-E7B2-4DBF-9AE1-0C280716D4C2Q37372519-06666C20-8FD0-49CE-ABC2-F21EF6D213EBQ37395821-EAD795DD-D0B1-4D1B-9F55-EE2A1557C0FCQ38765477-93961B2F-8706-4BC8-9BC5-46B2C26037C3Q39495489-DB9CF9B9-47F8-4330-9EF7-D2E8BB4CE461Q39498622-335B923C-3FCE-47AB-9A6E-ED3086029733Q39778382-D80FC29B-ECF9-4FF1-B2D5-903506B8DDDAQ39851789-933E655F-32FF-430A-9642-A47B394AA439Q41845709-B8BEB2B3-D643-4A30-8605-7276B9EADD90Q47181119-0DBD0BBB-049A-479D-8F82-F12CA259F3AAQ49600966-59306496-08B2-4C29-B4A7-65C6C001DE58Q50100821-292409F2-A356-49AA-ABFD-9AC3855432B8Q51557293-B0F1B61F-1F0D-488A-8924-B24997C66100Q54521768-37E8253C-1827-4738-964E-4F25B4113ACAQ54671666-EFB536F8-FAC5-4B62-A4A9-48503479589FQ56896871-BE53F0FF-AF28-470E-902C-05F9DEA8170CQ58715258-9C35A293-0111-459F-BA5F-0799F2FF27FF
P2860
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Regulation of ornithine decarb ...... sms and therapeutic potential.
@ast
Regulation of ornithine decarb ...... sms and therapeutic potential.
@en
type
label
Regulation of ornithine decarb ...... sms and therapeutic potential.
@ast
Regulation of ornithine decarb ...... sms and therapeutic potential.
@en
prefLabel
Regulation of ornithine decarb ...... sms and therapeutic potential.
@ast
Regulation of ornithine decarb ...... sms and therapeutic potential.
@en
P1433
P1476
Regulation of ornithine decarb ...... isms and therapeutic potential
@en
P2093
P2888
P304
P356
10.1007/S00726-007-0531-2
P577
2007-04-19T00:00:00Z